chr10-31461211-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001174096.2(ZEB1):āc.233A>Cā(p.Asn78Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00281 in 1,613,224 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001174096.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZEB1 | NM_001174096.2 | c.233A>C | p.Asn78Thr | missense_variant | 2/9 | ENST00000424869.6 | NP_001167567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZEB1 | ENST00000424869.6 | c.233A>C | p.Asn78Thr | missense_variant | 2/9 | 5 | NM_001174096.2 | ENSP00000415961 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0151 AC: 2299AN: 152114Hom.: 42 Cov.: 32
GnomAD3 exomes AF: 0.00395 AC: 989AN: 250552Hom.: 21 AF XY: 0.00287 AC XY: 389AN XY: 135406
GnomAD4 exome AF: 0.00152 AC: 2226AN: 1460992Hom.: 51 Cov.: 31 AF XY: 0.00129 AC XY: 935AN XY: 726774
GnomAD4 genome AF: 0.0151 AC: 2302AN: 152232Hom.: 43 Cov.: 32 AF XY: 0.0139 AC XY: 1035AN XY: 74452
ClinVar
Submissions by phenotype
Corneal dystrophy, Fuchs endothelial, 6 Pathogenic:1Benign:2
Benign, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | The ZEB1 gene is known as TCF8 in the published literature (PMID: 20036349). TCF8NM_030751.5:c.233A>C in the ZEB1 gene has an allele frequency of 0.052 in African subpopulation in the gnomAD database. 30 homozygous occurrences are observed in the gnomAD database. Since the Fuchs Corneal Dystrophy was reported as Late-Onset, we determined to not apply the number of homozygousity as a strong benign evidence. In addition, Riazuddin et al. reported a patient with Late-Onset Fuchs Corneal Dystrophy barboring p.N78T (PMID: 20036349). These evidence suggest the variant to be classified as benign. ACMG/AMP criteria applied: BA1. - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | Dec 24, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2010 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | research | H3Africa Consortium | Oct 28, 2020 | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.083, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. - |
ZEB1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 25, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 08, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at